#578 zhiwei
|
1: test |
|
|
0.000% |
Created |
#577 sub
|
1: Cc1cccc(C)c1OCC(=O)N[C@@H](Cc2ccccc2)[C@@H](O)C[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)N4CCCNC4=O |
|
|
0.000% |
Created |
#576 hulio
|
1: okng |
|
|
0.000% |
Created |
#537 Molnupiravir and Paxlovid
|
2: *** |
|
|
96.349% |
Finished with Errors |
#536 mini project 083023_YZ#3
|
3: Ritonavir; Nirmatrelvir; Molnupiravir |
|
|
99.683% |
Finished with Errors |
#507 Psp case study
|
2: Remdesivir; Remdesivir triphosphate |
|
|
72.857% |
Finished with Errors |
#425 Remdesivir and Remdesivir triphosphate
|
2: Remdesivir; Remdesivir triphosphate |
|
|
99.365% |
Finished with Errors |
#383 Ivermectin 01
|
1: Ivermectin 01 |
|
|
97.778% |
Finished with Errors |
#382 Ivermectin
|
1: Ivermectin |
|
|
74.603% |
Finished with Errors |
#351 DB01222-DB06145-DB09134-DB12865
|
4: DB01222; DB06145; DB12865; DB09134 |
|
|
99.756% |
Finished with Errors |
#348 DB00254-DB00511-DB00734-DB00917-DB00997
|
5: DB00254; DB00511; DB00997; DB00734; DB00917 |
|
|
99.902% |
Finished with Errors |
#342 ICV832-ICV837
|
5: ICV842; ICV835; ICV837; ICV833; ICV832 |
|
|
99.415% |
Finished with Errors |
#308 RG2_VIRAL_3
|
4: LIGAND 137; LIGAND_65; LIGAND 70; LIGAND 40 |
|
|
95.854% |
Finished with Errors |
#288 RG2_VIRAL_2
|
5: MOLECULE 127; MOLECULE 25; MOLECULE 78; MOLECULE 177; MOLECULE 20 |
|
|
91.415% |
Finished with Errors |
#280 RG_COVID
|
2: MOLECULE 78; MOLECULE 20 |
|
|
97.317% |
Finished with Errors |
#190 Potential combinationv2
|
4: Proscillaridin; Anidulafungin; Eltrombopag; Imatinib |
|
|
97.927% |
Finished with Errors |
#185 Potential combination
|
5: Digoxin; Proscillaridin; Anidulafungin; Eltrombopag; Imatinib |
|
|
98.341% |
Finished with Errors |
#176 new spider plot
|
4: Digoxin; Proscillaridin; Anidulafungin; Eltrombopag |
|
|
97.805% |
Finished with Errors |
#174 SARS2v4
|
5: Tetrandrine; Berbamine; Anidulafungin; Gilteritinib; Abemaciclib |
|
|
98.041% |
Finished with Errors |
#171 SARS2v1
|
5: Amodiaquine; Cyclosporine; Loperamide; Tilorone; Mefloquine |
|
|
93.299% |
Finished with Errors |
#170 Atazanavir Sulfate
|
1: Atazanavir Sulfate |
|
|
99.485% |
Finished with Errors |
#134 Daclatasvir
|
1: Daclatasvir |
|
|
99.485% |
Finished with Errors |
#133 Ledipasvir
|
1: Ledipasvir |
|
|
97.938% |
Finished with Errors |
#132 Voxilaprevir
|
1: Voxilaprevir |
|
|
99.485% |
Finished with Errors |
#104 4-Drugs-Combination
|
4: Saquinavir; Bictegravir; Ledipasvir; Oseltamivir |
|
|
99.485% |
Finished with Errors |
#92 LTJv16
|
5: Glecaprevir; Pibrentasvir; Raltegravir; Doravirine; Fosamprenavir |
|
|
99.381% |
Finished with Errors |
#90 LTJv14
|
5: Elvitegravir; Daclatasvir; Amantadine; Ritonavir; Tenofovir alafenamide |
|
|
99.897% |
Finished with Errors |
#86 LTJv10
|
5: Cidofovir; Efavirenz; Peramivir; Valaciclovir; Velpatasvir |
|
|
99.278% |
Finished with Errors |
#85 LTJv9
|
5: Grazoprevir; Tenofovir disoproxil; Asunaprevir; Penciclovir; Voxilaprevir |
|
|
99.897% |
Finished with Errors |
#82 LTJv5
|
5: Elbasvir; Famciclovir; Ledipasvir; Ombitasvir; Sofosbuvir |
|
|
98.763% |
Finished with Errors |
#79 LTJv3
|
5: Lopinavir; Cobicistat; Lisinopril; Ramipril; Moexipril |
|
|
99.897% |
Finished with Errors |
#581 WIN
|
1: WIN |
|
|
100.000% |
Finished |
#579 test
|
1: CN(C)C(=N)/N=C(N)/N |
|
|
100.000% |
Finished |
#572 test
|
1: m |
|
|
100.000% |
Finished |
#571 TestJ
|
1: Y |
|
|
100.000% |
Finished |
#570 Test
|
1: X |
|
|
100.000% |
Finished |
#569 abbas
|
1: mangefirine |
|
|
100.000% |
Finished |
#568 abbas
|
1: Mangiferin |
|
|
100.000% |
Finished |
#567 Kabi molecule
|
1: Zingerone |
|
|
100.000% |
Finished |
#566 Mansi
|
1: 6-thioguanosine |
|
|
100.000% |
Finished |
#564 Udenafil
|
1: Udenafil |
|
|
100.000% |
Finished |
#563 Remdesivir-Sep30
|
1: Remdesivir |
|
|
100.000% |
Finished |
#562 Remdesivir-Sep28
|
1: Remdesivir |
|
|
100.000% |
Finished |
#561 Remdesivir
|
1: Remdesivir |
|
|
100.000% |
Finished |
#560 Molnupiravir and Paxlovid
|
2: *** |
|
|
100.000% |
Finished |
#559 AG_MINIPRJ_NEW
|
2: *** |
|
|
100.000% |
Finished |
#558 new test
|
1: new test |
|
|
100.000% |
Finished |
#557 woaishixiong1
|
3: *** |
|
|
100.000% |
Finished |
#556 Miniproject HZ
|
2: *** |
|
|
100.000% |
Finished |
#555 Mini_Proj
|
3: *** |
|
|
100.000% |
Finished |
#554 New PSP MINI PROJECT
|
2: *** |
|
|
100.000% |
Finished |
#553 Junnan psp mini project 1
|
2: *** |
|
|
100.000% |
Finished |
#552 mini project 091823_YZ
|
3: *** |
|
|
100.000% |
Finished |
#551 Mini-Proj_2
|
2: *** |
|
|
100.000% |
Finished |
#550 Miniproj
|
2: *** |
|
|
100.000% |
Finished |
#549 Virus-CKB
|
2: *** |
|
|
100.000% |
Finished |
#548 ZEYU 0918 M+N+R
|
3: *** |
|
|
100.000% |
Finished |
#547 ZEYU 0918 M+R
|
2: *** |
|
|
100.000% |
Finished |
#546 Henry mini project
|
2: *** |
|
|
100.000% |
Finished |
#545 Henry mini project
|
1: Molnupiravir |
|
|
100.000% |
Finished |
#544 Junnan psp project1
|
2: *** |
|
|
100.000% |
Finished |
#543 AG_Mini project_PSPII
|
2: *** |
|
|
100.000% |
Finished |
#542 case_study_1
|
2: *** |
|
|
100.000% |
Finished |
#541 TVL_MiniProject1_092123
|
3: *** |
|
|
100.000% |
Finished |
#540 Aseel2023-2
|
1: Thioamide |
|
|
100.000% |
Finished |
#539 aseel2023
|
1: HSRA1 |
|
|
100.000% |
Finished |
#538 Boro-Mini-Project #1
|
3: *** |
|
|
100.000% |
Finished |
#535 mini project 083023_YZ#2
|
2: *** |
|
|
100.000% |
Finished |
#534 mini project 083023_YZ
|
2: Paxlovid; Molnupiravir |
|
|
100.000% |
Finished |
#533 PSP_case1_Yiyang
|
2: *** |
|
|
100.000% |
Finished |
#532 Shambhavi PSP mini project 1
|
2: *** |
|
|
100.000% |
Finished |
#531 PSP-case1
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#530 PSP-MP-AJR
|
2: Paxlovid; Molnupiravir |
|
|
100.000% |
Finished |
#529 Athbah's mini project 1
|
3: *** |
|
|
100.000% |
Finished |
#528 AA - Take-home Assignment 1
|
2: *** |
|
|
100.000% |
Finished |
#527 Ash-takehome
|
2: *** |
|
|
100.000% |
Finished |
#526 Ryan-Mini-Project-1
|
2: Paxlovid; Molnupiravir |
|
|
100.000% |
Finished |
#525 Tien-PSP Mini Project
|
3: *** |
|
|
100.000% |
Finished |
#524 PSP_case1_Yiyang
|
1: Remdesivir triphosphate |
|
|
100.000% |
Finished |
#523 PSP_case1_Yiyang
|
1: Remdesivir triphosphate |
|
|
100.000% |
Finished |
#522 PSP_1st class
|
2: Remdesvir; Remdesvir triphosphate |
|
|
100.000% |
Finished |
#521 PSP-case1
|
2: Remdesivir; Remdesivir Triphosphate |
|
|
100.000% |
Finished |
#520 PSP case study
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#519 woaishixiong
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#518 01-Case
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#517 PAP
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#516 test 1
|
2: Remdesivir; PubChem Remdesivir triphosphate |
|
|
100.000% |
Finished |
#515 RBoro
|
2: remdesivir; remdesivir triphosphate |
|
|
100.000% |
Finished |
#514 Ash-case1
|
2: Remdesivir; Remdesivir Triphosphate |
|
|
100.000% |
Finished |
#513 Case-8.29.23
|
2: Remdesivir; Remdesivir Triphosphate |
|
|
100.000% |
Finished |
#512 case-1
|
2: remdesivir; remdesiver triphosphate |
|
|
100.000% |
Finished |
#511 PSP-caseTien
|
2: remdesivir; remdesivir triphosphate |
|
|
100.000% |
Finished |
#510 PSP-case1
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#509 ZY_0829_01
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#508 PSP-case1
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#506 PSP-case_study2
|
1: Remdesivir triphosphate |
|
|
100.000% |
Finished |
#505 PSP-case study 1
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#504 PSP-casestudy1
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#503 PSP-case_study1
|
1: Remdesivir |
|
|
100.000% |
Finished |
#502 PSP- case study
|
1: Remdesivir |
|
|
100.000% |
Finished |
#498 Case_study_1_mini
|
2: Paxlovid; Molnupiravir |
|
|
100.000% |
Finished |
#497 case_study_1_1
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#494 PSP-case study
|
2: Remdesivir; Remdesivir triphosphate |
|
|
100.000% |
Finished |
#491 Remdesivir
|
1: Remdesivir |
|
|
100.000% |
Finished |
#483 dsfsaf
|
1: Aspirin |
|
|
100.000% |
Finished |
#482 NP2023
|
2: HAF-1; HAF-2 |
|
|
100.000% |
Finished |
#481 MM_04_CF3_trans
|
2: *** |
|
|
100.000% |
Finished |
#480 j
|
1: m |
|
|
100.000% |
Finished |
#477 Aseel2023
|
1: Tar2023 |
|
|
100.000% |
Finished |
#469 sameer
|
1: aseel |
|
|
100.000% |
Finished |
#468 HanyEmary
|
2: Phenylpyrazolone2; Phenylpyrazolone1 |
|
|
100.000% |
Finished |
#465 ll
|
1: ll |
|
|
100.000% |
Finished |
#464 Ethanol2 with someone
|
1: Ethanol |
|
|
100.000% |
Finished |
#463 Ethanol with someone
|
1: Ethanol |
|
|
100.000% |
Finished |
#455 MM_test_1
|
4: MM174; MM173; MM167; MM166 |
|
|
100.000% |
Finished |
#452 Remdesivir
|
1: Remdesivir |
|
|
100.000% |
Finished |
#451 CHEMBL415
|
1: CHEMBL415 |
|
|
100.000% |
Finished |
#450 CHEMBL415
|
1: CHEMBL415 |
|
|
100.000% |
Finished |
#449 111
|
1: minocycline |
|
|
100.000% |
Finished |
#448 Compare 1
|
2: Comp3; Comp2 |
|
|
100.000% |
Finished |
#447 Comp1
|
1: Comp1 |
|
|
100.000% |
Finished |
#446 benzene
|
1: benzene |
|
|
100.000% |
Finished |
#445 trial
|
2: molecule_mod; molecule |
|
|
100.000% |
Finished |
#444 drug
|
1: aspirin |
|
|
100.000% |
Finished |
#443 wep32
|
4: 4a; 4b; 3b; 4c |
|
|
100.000% |
Finished |
#442 wep31
|
5: 4a; 4b; 3b; 4c; 3a |
|
|
100.000% |
Finished |
#441 we30
|
5: 4a; 4b; 3b; 4c; 3c |
|
|
100.000% |
Finished |
#440 we26
|
3: 2b; 2a; 2c |
|
|
100.000% |
Finished |
#439 wep28
|
3: 4a; 4b; 4c |
|
|
100.000% |
Finished |
#438 wep27
|
3: 3b; 3a; 3c |
|
|
100.000% |
Finished |
#437 me
|
1: ddapgme |
|
|
100.000% |
Finished |
#436 WEP3
|
5: DDAPG; DDBPG; DDAPGME; DDVPG; DDAPGBENZ |
|
|
100.000% |
Finished |
#435 WEP2
|
3: DBPG; DAPG; DVPG |
|
|
100.000% |
Finished |
#434 WEP1
|
3: MBPG; MAPG; MVPG |
|
|
100.000% |
Finished |
#433 MA
|
1: MA |
|
|
100.000% |
Finished |
#432 sar
|
2: ma; mb |
|
|
100.000% |
Finished |
#431 Aspirin
|
1: Aspirin |
|
|
100.000% |
Finished |
#427 Galidesivir and Tenofovir
|
2: Galidesivir; Tenofovir |
|
|
100.000% |
Finished |
#426 Galidesivir and Galidesivir triphosphate form 1
|
2: Galidesivir triphosphate form; Galidesivir |
|
|
100.000% |
Finished |
#424 Galidesivir and Galidesivir triphosphate form
|
2: Galidesivir triphosphate form; Galidesivir |
|
|
100.000% |
Finished |
#423 Tenofovir and Galidesivir
|
2: Tenofovir; Galidesivir |
|
|
100.000% |
Finished |
#422 Galidesivir and Ribavirin
|
2: Ribavirin; Galidesivir |
|
|
100.000% |
Finished |
#421 Nirmatrelvir and Ritonavir combination
|
2: Ritonavir; Nirmatrelvir |
|
|
100.000% |
Finished |
#420 Ritonavir
|
1: Ritonavir |
|
|
100.000% |
Finished |
#419 Nirmatrelvir modification 02
|
2: Nirmatrelvir; Nirmatrelvir Modify 02 |
|
|
100.000% |
Finished |
#418 Nirmatrelvir modification
|
2: Nirmatrelvir Modify; Nirmatrelvir |
|
|
100.000% |
Finished |
#417 Nirmatrelvir
|
1: Nirmatrelvir |
|
|
100.000% |
Finished |
#416 Yixuan's drug22-virus-ckb2
|
2: Telaprevir; Telaprevir01 |
|
|
100.000% |
Finished |
#415 Telaprevir
|
1: Telaprevir |
|
|
100.000% |
Finished |
#414 Telaprevir
|
1: Telaprevir |
|
|
100.000% |
Finished |
#413 jj
|
1: jj |
|
|
100.000% |
Finished |
#412 jj
|
1: jj |
|
|
100.000% |
Finished |
#411 jj
|
1: jj |
|
|
100.000% |
Finished |
#410 jjj
|
1: jjj |
|
|
100.000% |
Finished |
#409 JJJ002
|
1: JJJ002 |
|
|
100.000% |
Finished |
#408 Trial JJJ
|
1: JJ001 |
|
|
100.000% |
Finished |
#407 Trial JJ
|
1: sultam1 |
|
|
100.000% |
Finished |
#406 Telaprevir
|
1: Telaprevir |
|
|
100.000% |
Finished |
#405 Telaprevir
|
1: Telaprevir |
|
|
100.000% |
Finished |
#404 Boceprevir
|
1: Boceprevir |
|
|
100.000% |
Finished |
#403 Telaprevir
|
1: Telaprevir |
|
|
100.000% |
Finished |
#396 Edns
|
1: Pht |
|
|
100.000% |
Finished |
#391 JANZ-2
|
1: erastin |
|
|
100.000% |
Finished |
#390 JANZ-erastin
|
1: erastin |
|
|
100.000% |
Finished |
#389 JANZ-1
|
1: erastin |
|
|
100.000% |
Finished |
#387 Drug combination for HCV treatment
|
3: Brequinar; Niclosamide; Sofosbuvir |
|
|
100.000% |
Finished |
#386 Policresulen
|
1: Policresulen |
|
|
100.000% |
Finished |
#385 Carnosine
|
1: Carnosine |
|
|
100.000% |
Finished |
#384 Drug combination for dengue treatment
|
2: Sunitinib; Erlotinib |
|
|
100.000% |
Finished |
#378 WEP
|
5: Pyranojacareubin; Soulattrin; Phylattrin; Inophinnin; Inophinone |
|
|
100.000% |
Finished |
#376 wep
|
1: C1 |
|
|
100.000% |
Finished |
#373 Yixuan's drug11-virus-ckb2
|
4: Remdesivir; Telaprevir; Boceprevir; Narlaprevir |
|
|
100.000% |
Finished |
#362 Docking-2
|
1: Resvertrol |
|
|
100.000% |
Finished |
#361 docking 1
|
1: baicalein |
|
|
100.000% |
Finished |
#360 wep
|
3: Naringenin; Luteolin; N3 |
|
|
100.000% |
Finished |
#359 sar
|
1: pyrazinamide |
|
|
100.000% |
Finished |
#358 12121
|
2: 3; 2 |
|
|
100.000% |
Finished |
#357 Clase proteomica
|
1: Virus T |
|
|
100.000% |
Finished |
#356 wep2
|
3: DDAPG; DDBPG; DDVPG |
|
|
100.000% |
Finished |
#354 wep
|
1: aa |
|
|
100.000% |
Finished |
#353 wep
|
3: Naringenin; Luteolin; N3 |
|
|
100.000% |
Finished |
#350 DB00279-DB00558-DB00800-DB00947-DB01061
|
5: DB00800; DB00558; DB01061; DB00947; DB00279 |
|
|
100.000% |
Finished |
#349 DB01211-DB04825-DB09050-DB12839-DB15305
|
5: DB12839; DB01211; DB04825; DB09050; DB15305 |
|
|
100.000% |
Finished |
#347 DB01196-DB01380-DB06796-DB09403-DB14650
|
5: DB01380; DB01196; DB09403; DB06796; DB14650 |
|
|
100.000% |
Finished |
#346 DB00223-DB00374-DB00663-DB00838-DB00984
|
5: DB00374; DB00984; DB00663; DB00838; DB00223 |
|
|
100.000% |
Finished |
#345 DB01092-DB01256-DB06288-DB09164-DB13279
|
5: DB09164; DB01256; DB06288; DB13279; DB01092 |
|
|
100.000% |
Finished |
#344 DB00176-DB00367-DB00562-DB00833-DB00955
|
5: DB00176; DB00955; DB00833; DB00367; DB00562 |
|
|
100.000% |
Finished |
#343 AAR
|
1: Warfarin |
|
|
100.000% |
Finished |
#341 ICV827-ICV831
|
5: ICV830; ICV829; ICV827; ICV831; ICV828 |
|
|
100.000% |
Finished |
#340 ICV822-ICV826
|
5: ICV822; ICV825; ICV824; ICV823; ICV826 |
|
|
100.000% |
Finished |
#339 ICV817-ICV821
|
5: ICV821; ICV817; ICV818; ICV820; ICV819 |
|
|
100.000% |
Finished |
#338 ICV812-ICV816
|
5: ICV814; ICV813; ICV816; ICV815; ICV812 |
|
|
100.000% |
Finished |
#337 ICV807-ICV811
|
5: ICV807; ICV811; ICV808; ICV809; ICV810 |
|
|
100.000% |
Finished |
#336 ICV802-ICV842
|
5: ICV805; ICV804; ICV802; ICV806; ICV803 |
|
|
100.000% |
Finished |
#335 TEST
|
3: ICV339; ICV346; ICV333 |
|
|
100.000% |
Finished |
#334 ICV801
|
1: ICV801 |
|
|
100.000% |
Finished |
#333 ICV346
|
1: ICV346 |
|
|
100.000% |
Finished |
#332 ICV333
|
1: ICV333 |
|
|
100.000% |
Finished |
#331 ICV339
|
1: ICV339 |
|
|
100.000% |
Finished |
#330 vc17
|
3: 2 Coumarinate; 3; 2 |
|
|
100.000% |
Finished |
#329 drug target
|
1: chloroquine |
|
|
100.000% |
Finished |
#328 Youshen-test
|
1: *** |
|
|
100.000% |
Finished |
#327 KK01
|
1: Seed1 |
|
|
100.000% |
Finished |
#326 vc1784
|
2: 2 Coumarinate; Agapanthagenin |
|
|
100.000% |
Finished |
#325 C MILI.1
|
1: Cordyceps polysaccharide |
|
|
100.000% |
Finished |
#316 Project M-ASB-S
|
1: Loperamide |
|
|
100.000% |
Finished |
#315 Project M-ASB-S
|
1: Loperamide |
|
|
100.000% |
Finished |
#314 Project M-ASB-S
|
1: Loperamide |
|
|
100.000% |
Finished |
#313 Project M-ASB-S
|
1: Loperamid |
|
|
100.000% |
Finished |
#312 Project M-ASB-S
|
1: Ribavirin |
|
|
100.000% |
Finished |
#311 Project M-ASB-S
|
1: Ribavirin |
|
|
100.000% |
Finished |
#310 What if
|
1: Tetrahydrocannabinol |
|
|
100.000% |
Finished |
#307 Aspirin test
|
1: Aspirin |
|
|
100.000% |
Finished |
#306 Ethane test
|
1: Ethane |
|
|
100.000% |
Finished |
#305 test
|
1: test |
|
|
100.000% |
Finished |
#301 Woo test
|
1: Aspirin |
|
|
100.000% |
Finished |
#287 BIOTEKNOLOGI 2020
|
1: Chloroquine |
|
|
100.000% |
Finished |
#281 Darko - curcumin
|
1: curcumin |
|
|
100.000% |
Finished |
#279 Sarscov_1
|
2: Redemsivir; Cloroquine |
|
|
100.000% |
Finished |
#277 VIRUS-CKB
|
1: Tanimoto |
|
|
100.000% |
Finished |
#276 sample1-SARS-CoV-2/WA6-UW3/human/2020/USA
|
1: aspirine |
|
|
100.000% |
Finished |
#275 remdesivir
|
1: remdesivir |
|
|
100.000% |
Finished |
#266 Hydroxychloroquine
|
1: Hydroxychloroquine |
|
|
100.000% |
Finished |
#260 1
|
3: Tanshinol; Salvianolic acid B; Rutin |
|
|
100.000% |
Finished |
#259 1
|
5: Rosmarinic acid; Hyperoside; Quercetin; Luteolin; protocatechuic acid |
|
|
100.000% |
Finished |
#258 1
|
5: Ethyl ferulate; Galuteolin; Ferulic acid; Cryptotanshinone; Chlorogenic acid |
|
|
100.000% |
Finished |
#257 1
|
5: Albiflorin; Benzoylpaeoniflorin; Apigenin; Caffeic acid; Butylidenephthalide |
|
|
100.000% |
Finished |
#256 0
|
5: 3; 5; 4; 2; 1 |
|
|
100.000% |
Finished |
#255 0
|
5: 1; 3; 2; 5; 4 |
|
|
100.000% |
Finished |
#254 gdsg
|
5: ggggg; fdagfh; fghsfhsfh; dfdggg; dfgfgfg |
|
|
100.000% |
Finished |
#252 111
|
1: 222 |
|
|
100.000% |
Finished |
#251 1
|
1: 1 |
|
|
100.000% |
Finished |
#250 ZWJZWJ2
|
1: 5H |
|
|
100.000% |
Finished |
#248 ZWJZWJ
|
1: Luteolin |
|
|
100.000% |
Finished |
#239 Test
|
1: Harmony_1 |
|
|
100.000% |
Finished |
#238 Compound test
|
1: 617 |
|
|
100.000% |
Finished |
#237 Remdesivir
|
1: *** |
|
|
100.000% |
Finished |
#236 Sitagliptin
|
1: Sitagliptin |
|
|
100.000% |
Finished |
#235 3 drugs
|
3: Ebselen; Shikonin; Tideglusib |
|
|
100.000% |
Finished |
#232 stat
|
1: sta2 |
|
|
100.000% |
Finished |
#231 Remdesivir
|
1: Remdesivir |
|
|
100.000% |
Finished |
#195 ligands in co-crystal
|
5: AMP-NSP3; S-Adenosylmethionine-NSP16; SCHEMBL17719237-RDRP; MLN-4760-ACE2; GTPL10716-3CLPro |
|
|
100.000% |
Finished |
#194 X3
|
1: X3 |
|
|
100.000% |
Finished |
#193 CB2_compounds
|
3: WIN55212-2; PY1-61; PY2-64 |
|
|
100.000% |
Finished |
#192 p62_compounds_2
|
4: XIE2008; XIE5-2-35; XIE5-2-9; XIE5-2-17 |
|
|
100.000% |
Finished |
#191 p62_compounds
|
5: XRK3F2; XIE5-1-23; XIE5-2-25; XRK3; XIE106 |
|
|
100.000% |
Finished |
#188 New test
|
5: Nelfinavir; Conivaptan; Tipranavir; Dihydroergotamine; Eltrombopag |
|
|
100.000% |
Finished |
#187 Digoxin+Proscillaridin+Eltrombopag
|
3: Digoxin; Proscillaridin; Eltrombopag |
|
|
100.000% |
Finished |
#186 Remdesivir+Chloroquine
|
2: Remdesivir; Chloroquine |
|
|
100.000% |
Finished |
#184 Remdesivirv+Chloroquine
|
2: Remdesivirv; Chloroquine |
|
|
100.000% |
Finished |
#183 New v2
|
5: Chlorpromazine; Amodiaquine; Amodiaquine hydrochloride; Mefloquine; Imatinib |
|
|
100.000% |
Finished |
#182 New v1
|
5: Enisamium iodide; Umifenovir; Ribavirin; Favipiravir; Sofosbuvir |
|
|
100.000% |
Finished |
#181 Remdesivirv2
|
3: Remdesivir Nucleoside; Remdesivir; Remdesivir Nucleoside Triphosphate |
|
|
100.000% |
Finished |
#180 Remdesivir Nucleoside Triphosphate
|
1: Remdesivir Nucleoside Triphosphate |
|
|
100.000% |
Finished |
#179 Remdesivir
|
1: Remdesivir |
|
|
100.000% |
Finished |
#178 hh
|
1: hh |
|
|
100.000% |
Finished |
#175 SARS2v5
|
4: Bazedoxifene; Ivacaftor; Niclosamide; Eltrombopag |
|
|
100.000% |
Finished |
#173 SARS2v3
|
5: Oxyclozanide; Ouabain; Salinomycin; Ciclesonide; Cepharanthine |
|
|
100.000% |
Finished |
#172 SARS2v2
|
5: Digoxin; Hexachlorophene; Digitoxin; Proscillaridin; Hydroxyprogesterone caproate |
|
|
100.000% |
Finished |
#169 Atazanavir
|
1: Atazanavir |
|
|
100.000% |
Finished |
#166 lvkui
|
1: lvkui |
|
|
100.000% |
Finished |
#165 2-17
|
1: 2-17 |
|
|
100.000% |
Finished |
#164 5-2-9
|
1: 5-2-9 |
|
|
100.000% |
Finished |
#163 melatonin
|
1: melatonin |
|
|
100.000% |
Finished |
#162 Melatonin
|
1: Melatonin |
|
|
100.000% |
Finished |
#161 Umifenovir
|
1: Umifenovir |
|
|
100.000% |
Finished |
#160 Glucocorticoid
|
1: Glucocorticoid |
|
|
100.000% |
Finished |
#159 Moexipril
|
1: Moexipril |
|
|
100.000% |
Finished |
#158 Linezolid
|
1: Linezolid |
|
|
100.000% |
Finished |
#157 Mercaptopurine_melatonin_asiprin
|
3: asiprin; Mercaptopurine; melatonin |
|
|
100.000% |
Finished |
#156 Dolutegravir/Abacavir/Lamivudine
|
3: Lamivudine; Abacavir; Dolutegravir |
|
|
100.000% |
Finished |
#155 bictegravir/emtricitabine/tenofovir alafenamide
|
3: bictegravir; emtricitabine; tenofovir alafenamide |
|
|
100.000% |
Finished |
#137 Jaden-test
|
1: sultam |
|
|
100.000% |
Finished |
#136 Captopril
|
1: Captopril |
|
|
100.000% |
Finished |
#135 Lisinopril
|
1: Lisinopril |
|
|
100.000% |
Finished |
#131 Dolutegravir
|
1: Dolutegravir |
|
|
100.000% |
Finished |
#130 Saquinavir
|
1: Saquinavir |
|
|
100.000% |
Finished |
#129 Paritaprevir
|
1: Paritaprevir |
|
|
100.000% |
Finished |
#128 Bictegravir
|
1: Bictegravir |
|
|
100.000% |
Finished |
#127 Azithromycin
|
1: Azithromycin |
|
|
100.000% |
Finished |
#126 ZHIWEI'S TESTING
|
1: Remdesivir |
|
|
100.000% |
Finished |
#124 Test1
|
1: Test1 |
|
|
100.000% |
Finished |
#123 test_too
|
1: asprin |
|
|
100.000% |
Finished |
#122 5-Drugs
|
1: Remdesivir |
|
|
100.000% |
Finished |
#121 5-Drugs
|
1: Remdesivir |
|
|
100.000% |
Finished |
#120 Azithromycin
|
1: Azithromycin |
|
|
100.000% |
Finished |
#119 5 Drug Combinations
|
5: Bictegravir; Paritaprevir; Glimepiride; Fedratinib; Oseltamivir |
|
|
100.000% |
Finished |
#118 5-Drug-Combination
|
5: Bictegravir; Remdesivir; Glimepiride; Fedratinib; Oseltamivir |
|
|
100.000% |
Finished |
#117 5-Drugs
|
1: Remdesivir |
|
|
100.000% |
Finished |
#116 Diabete
|
5: Linagliptin; Acarbose; Glimepiride; Rosiglitazone; Repaglinide |
|
|
100.000% |
Finished |
#115 Anti-Inflammatory v3
|
5: Hydrocortisone; Flurandrenolide; Fluticasone propionate; Triamcinolone; Beclomethasone dipropionate |
|
|
100.000% |
Finished |
#114 Anti-Inflammatory v2
|
5: Bendazac; Nepafenac; Cortisone acetate; Bromfenac; Flurbiprofen |
|
|
100.000% |
Finished |
#113 Anti-Inflammatory v1
|
1: Ketorolac |
|
|
100.000% |
Finished |
#112 Hydroxychloroquine
|
2: Hydroxychloroquine; Chloroquine |
|
|
100.000% |
Finished |
#111 Umifenovir
|
1: Umifenovir |
|
|
100.000% |
Finished |
#110 Remdesivir
|
1: Remdesivir |
|
|
100.000% |
Finished |
#106 3-DRUGS
|
3: Saquinavir; Bictegravir; Paritaprevir |
|
|
100.000% |
Finished |
#105 Drugs Combinations
|
4: Saquinavir; Bictegravir; Paritaprevir; Oseltamivir |
|
|
100.000% |
Finished |
#103 3-Drugs-Combinations
|
3: Saquinavir; Bictegravir; Oseltamivir |
|
|
100.000% |
Finished |
#102 Chloro
|
1: Chloro |
|
|
100.000% |
Finished |
#101 TEST
|
1: TEST |
|
|
100.000% |
Finished |
#100 LTJv19
|
5: Canagliflozin; Metformin; Glimepiride; Glipizide; Sitagliptin |
|
|
100.000% |
Finished |
#99 Danoprevir
|
1: Danoprevir |
|
|
100.000% |
Finished |
#98 Oseltamivir
|
1: Oseltamivir |
|
|
100.000% |
Finished |
#97 3-Drugs-Combinations
|
3: Saquinavir; Bictegravir; Telaprevir |
|
|
100.000% |
Finished |
#93 LTJv17
|
5: 1-deoxymannojirimycin; Etravirine; Amprenavir; Letermovir; Tipranavir |
|
|
100.000% |
Finished |
#91 LTJv15
|
5: Zanamivir; Ganciclovir; Acyclovir; Entecavir; Trifluridine |
|
|
100.000% |
Finished |
#89 LTJv13
|
5: Abacavir; Dolutegravir; Boceprevir; Ribavirin; Edoxudine |
|
|
100.000% |
Finished |
#88 LTJv12
|
5: Saquinavir; Valganciclovir; Nelfinavir; Rilpivirine; Foscarnet |
|
|
100.000% |
Finished |
#87 LTJv11
|
5: Indinavir; Lamivudine; Paritaprevir; Delavirdine; Atazanavir |
|
|
100.000% |
Finished |
#84 LTJv8
|
5: Dasabuvir; Telaprevir; Idoxuridine; Nevirapine; Rimantadine |
|
|
100.000% |
Finished |
#83 LTJv7
|
5: Bictegravir; Darunavir; Baloxavir marboxil; Simeprevir; Adefovir dipivoxil |
|
|
100.000% |
Finished |
#81 LTJv5
|
4: Baricitinib; Ruxolitinib; Diclofenac; Fedratinib |
|
|
100.000% |
Finished |
#80 LTJv4
|
5: Acetylsalicylic acid; Indomethacin; Ibuprofen; Fenbufen; Ritonavir |
|
|
100.000% |
Finished |
#78 LTJv2
|
5: Captopril; zanamivir; Laninamivir; oseltamivir; baloxavir |
|
|
100.000% |
Finished |
#77 LTJv1
|
4: Fosinopril; abacavir; Atazanavir; Peramivir |
|
|
100.000% |
Finished |